STAR-0310

N/A

Report date: 2025/09/25 17:45:02

Base Information

Drug NameSTAR-0310
Drug Alias NameSTAR-0310STR-310ISB-830-X8
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 4Antibody-dependent cell-mediated cytotoxicity (ADCC) effects
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIchnos Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstria Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A